Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Case report: response to immunotherapy and association with the fh gene in hereditary leiomyomatosis and renal cell cancer-associated renal cell cancer

Fig. 3

The patient had new metastatic lesions after surgery but showed a response during immunotherapy. At 3 months after surgery, CT revealed metastatic lesions in both lungs and the pleura. The lung lesions were stable until November 2021 after sintilimab and anlotinib treatment. With the switch to pembrolizumab and axitinib, the lung lesion showed a partial response in October 2022

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us